Evidence map›Paper›PMID 34064899›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Gold Nanoparticles Prepared with

Rongbo Wang, Xingyue Xu, Aditi Mitra Puja, Haribalan Perumalsamy, Sri Renukadevi Balusamy, Hoon Kim, Yeon-Ju Kim

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Biologically SynthesizedACS omega · 2022
    Article
  11. Article
  12. Article
  13. Biologically synthesis of gold nanoparticles usingInternational journal of biological sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rongbo WangGraduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin-si 17104, Korea.
Xingyue XuGraduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin-si 17104, Korea.
Aditi Mitra PujaGraduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin-si 17104, Korea.
Haribalan PerumalsamyGraduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin-si 17104, Korea.ORCID 0000-0002-6497-5857
Sri Renukadevi BalusamyDepartment of Food Science and Biotechnology, Sejong University, Gwangjin-gu, Seoul 05006, Korea.ORCID 0000-0002-8119-2504
Hoon KimDepartment of Oriental Medicine Biotechnology, Kyung Hee University, Yongin-si 17104, Korea.ORCID 0000-0001-9153-382X
Yeon-Ju KimGraduate School of Biotechnology, College of Life Science, Kyung Hee University, Yongin-si 17104, Korea.
Kyung Hee University · KRSejong University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Nanotechnology is being widely applied for anticancer strategies with few side effects. Nanoparticles (NPs) prepared from natural extracts are promising candidates for cancer treatment because of their unique physicochemical characteristics. This study aimed to prepare gold nanoparticles (AuNPs) from

Indexed as

apoptosisautophagyBifidobacterium animalis subsp. lactisgastric cancergold nanoparticlesPhyllanthus emblica fruit

Identifiers

PMID34064899
PMCPMC8150816
OpenAlexW3163383217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.